Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

The Department of Health and Mental Hygiene

skip to content | access shortcuts

DHMH Press Releases :

DHMH Press Releases > Posts > Three Maryland Meningitis Cases Associated with Injectable Steroids


October 06
Three Maryland Meningitis Cases Associated with Injectable Steroids

 Maryland Case Count and Outbreak Update Website Launched

Baltimore, MD (October 6, 2012) -- The Maryland Department of Health and Mental Hygiene (DHMH), in conjunction with other states, the Centers for Disease Control and Prevention (CDC), and the US Food and Drug Administration (FDA), continues to investigate an association between spinal injections and the development of meningitis as part of a larger multi-state investigation. DHMH has now identified a third Maryland patient that developed meningitis after receiving an injection in September of an already implicated lot of methylprednisolone acetate that was produced and distributed by the New England Compounding Center (NECC).  

No additional case-specific information will be released. Including this newly identified case, DHMH has now identified three Maryland-associated cases, one of whom has died. As this investigation continues, the Department will post updates off its home page,  under “Meningitis Cases Associated with Injectable Steroids.” 
DHMH continues to urge people who have new or worsening symptoms, including symptoms of meningitis or stroke, following an injection of methylprednisolone acetate from one of the seven Maryland facilities that received the implicated NECC lots to contact their healthcare provider to determine if further evaluation is indicated. Symptoms of meningitis can include fever, headache, neck stiffness, photophobia, nausea, or vomiting. Stroke symptoms can include but are not limited to double vision, slurred speech, weakness on one side of the body, or difficulty walking.  
No other products have been implicated in this outbreak. However, NECC has recalled a number of other products, and CDC and FDA are advising all health care facilities with NECC products to stop using them.  To be vigilant for the possibility of further problems, anyone who develops signs of an infection following an injection or other medical procedure should check in with a healthcare provider.
Facilities that have received and pulled from use the affected product are:
Berlin Interventional Pain Management, Berlin, MD
Box Hill Surgery Center, Abingdon, MD
Greenspring Surgery Center, Baltimore, MD
Harford County Ambulatory Surgery Center, Edgewood, MD
Maryland Pain Specialists, Towson, MD
SurgCenter of Bel Air, Bel Air, MD
Zion Ambulatory Center, Baltimore, MD




There are no comments for this post.


There are no comments for this post.